{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:07:58Z","timestamp":1773770878370,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.2515\/therapie\/2010072","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T10:38:01Z","timestamp":1293014281000},"page":"543-550","source":"Crossref","is-referenced-by-count":12,"title":["DRESS syndrome : \u00e9tude de 11 cas et revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"65","author":[{"given":"Amel","family":"Chaabane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Aouam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Ben","family":"Fredj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naceur A","family":"Boughattas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2010072_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0151-9638(04)93600-9","article-title":"Syndrome d\u2019hypersensibilit\u00e9 m\u00e9dicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)","volume":"131","author":"Begon","year":"2004","journal-title":"Ann Dermatol Venereol"},{"key":"10.2515\/therapie\/2010072_bb0010","first-page":"1044","article-title":"Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"JEADV"},{"key":"10.2515\/therapie\/2010072_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000069956","article-title":"Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update","volume":"206","author":"Tas","year":"2003","journal-title":"Dermatology"},{"key":"10.2515\/therapie\/2010072_bb0020","first-page":"142","article-title":"Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"JDDG"},{"key":"10.2515\/therapie\/2010072_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","article-title":"Drug-induced hypersensitivity syndrome. Clinical and biologic disease patterns in 24 patients","volume":"88","author":"Ben Mrad","year":"2009","journal-title":"Medicine"},{"issue":"1","key":"10.2515\/therapie\/2010072_bb0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms. A cause of unpredictable multiorgan failure","volume":"145","author":"Eshki","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie\/2010072_bb0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention, and management","volume":"21","author":"Knowles","year":"1999","journal-title":"Drug Saf"},{"key":"10.2515\/therapie\/2010072_bb0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.2515\/therapie\/2010072_bb0045","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpes virus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.2515\/therapie\/2010072_bb0050","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.2515\/therapie\/2010072_bb0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","article-title":"General considerations for skin test procedures in the diagnosis of drug hypersensitivity","volume":"57","author":"Brokow","year":"2002","journal-title":"Allergy"},{"key":"10.2515\/therapie\/2010072_bb0060","first-page":"111","article-title":"Imputabilit\u00e9 des effets inattendus ou toxiques des m\u00e9dicaments. Actualisation de la m\u00e9thode utilis\u00e9e en France","volume":"40","author":"Begaud","year":"1985","journal-title":"Th\u00e9rapie"},{"key":"10.2515\/therapie\/2010072_bb0065","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM195006082422304","article-title":"Dilantin sensitivity: report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis","volume":"242","author":"Chaiken","year":"1950","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie\/2010072_bb0070","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archderm.134.7.874","article-title":"DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome","volume":"134","author":"Sontheimer","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie\/2010072_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.2515\/therapie\/2010072_bb0080","first-page":"364","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"13","author":"Kennebeck","year":"2000","journal-title":"J Am Board Fam Pract"},{"issue":"5","key":"10.2515\/therapie\/2010072_bb0085","first-page":"422","article-title":"Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome","volume":"17","author":"Petkov","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.2515\/therapie\/2010072_bb0090","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-4632.2008.03637.x","article-title":"Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review","volume":"47","author":"Ganeva","year":"2008","journal-title":"International Journal of Dermatology"},{"key":"10.2515\/therapie\/2010072_bb0095","first-page":"719","article-title":"Toxidermies avec atteinte pulmonaire","volume":"20","author":"Wolkenstein","year":"2003","journal-title":"Rev Mal Respir"},{"key":"10.2515\/therapie\/2010072_bb0100","first-page":"357","article-title":"The drug hypersensitivity syndrome: what is the pathogenesis?","volume":"137","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie\/2010072_bb0105","first-page":"22","article-title":"Minocycline-induced hypersensitivity syndrome presenting with meningitis and brain edema: a case report","volume":"1","author":"Lefebvre","year":"2007","journal-title":"JMed Case Reports"},{"issue":"6","key":"10.2515\/therapie\/2010072_bb0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0181-5512(06)73828-1","article-title":"DRESS syndrome associ\u00e9 \u00e0 une panuv\u00e9ite bilat\u00e9rale : \u00e0 propos d\u2019un cas","volume":"29","author":"Schauer","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.2515\/therapie\/2010072_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/17843286.1999.11754231","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)","volume":"54","author":"Tas","year":"1999","journal-title":"Acta Clin Belg"},{"key":"10.2515\/therapie\/2010072_bb0120","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterization of drug-specific T cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.2515\/therapie\/2010072_bb0125","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neurol.2009.02.009","article-title":"Anticonvulsant hypersensitivity syndrome and lamotrigine-associated anticonvulsant hypersensitivity syndrome","volume":"165","author":"Taillia","year":"2009","journal-title":"Rev Neurol"},{"key":"10.2515\/therapie\/2010072_bb0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/08860220701861045","article-title":"Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment","volume":"30","author":"Shalom","year":"2008","journal-title":"Renal Failure"},{"key":"10.2515\/therapie\/2010072_bb0135","first-page":"656","article-title":"Allopurinol-induced DRESS syndrome","volume":"7","author":"Markel","year":"2005","journal-title":"IMAJ"},{"issue":"5","key":"10.2515\/therapie\/2010072_bb0140","first-page":"560","article-title":"OchiM. A fatal case of drug-induced hypersensitivity syndrome due to allopurinol","volume":"58","author":"Gyotoku","year":"2009","journal-title":"Arerugi"},{"issue":"1","key":"10.2515\/therapie\/2010072_bb0145","first-page":"65","article-title":"Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis","volume":"61","author":"Gutierrez","year":"2009","journal-title":"Reumatismo"},{"issue":"4","key":"10.2515\/therapie\/2010072_bb0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1590\/S1516-31802008000400006","article-title":"Sulfasalazine induced DRESS syndrome","volume":"126","author":"Rudge de Aquino","year":"2008","journal-title":"Sao Paulo Med J"},{"key":"10.2515\/therapie\/2010072_bb0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0248-8663(01)00391-5","article-title":"DRESS syndrome \u00e0 la sulfasalazine et \u00e0 la carbamaz\u00e9pine : \u00e0 propos de deux cas","volume":"22","author":"Queyrel","year":"2001","journal-title":"Rev M\u00e9d Interne"},{"key":"10.2515\/therapie\/2010072_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaad.2008.07.044","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease","volume":"60","author":"Kawakami","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.2515\/therapie\/2010072_bb0165","first-page":"345","article-title":"Drug rash with eosinophilia and systemic symptoms after ibuprofen intake","volume":"17","author":"Kucharewicz","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.2515\/therapie\/2010072_bb0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3346\/jkms.2008.23.3.521","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs","volume":"23","author":"Lee","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.2515\/therapie\/2010072_bb0175","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.1996.03890320082013","article-title":"Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature","volume":"132","author":"Knowles","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie\/2010072_bb0180","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2007.01392.x","article-title":"DRESS syndrome from cefadroxil confirmed by positive patch test","volume":"62","author":"Suswardana","year":"2007","journal-title":"Allergy"},{"issue":"2","key":"10.2515\/therapie\/2010072_bb0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2169\/internalmedicine.45.1352","article-title":"Trimethoprim-sulfamethoxazoleinduced hypersensitivity syndrome associated with reactivation of human herpesvirus-6","volume":"45","author":"Morimoto","year":"2006","journal-title":"Intern Med"},{"issue":"3","key":"10.2515\/therapie\/2010072_bb0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1442-200X.2008.02603.x","article-title":"Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin","volume":"50","author":"Fujiwaki","year":"2008","journal-title":"Pediatr Int"},{"key":"10.2515\/therapie\/2010072_bb0195","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jinf.2005.10.028","article-title":"DRESS like severe drug rash with eosinophilia, atypic lymphocytosis and fever secondary to ceftriaxone","volume":"53","author":"Akcam","year":"2006","journal-title":"J Infec"},{"key":"10.2515\/therapie\/2010072_bb0200","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie\/2010072_bb0205","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1001\/archinte.161.20.2501","article-title":"DRESS syndrome associated with nevirapine therapy","volume":"161","author":"Claudio","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.2515\/therapie\/2010072_bb0210","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine, characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.2515\/therapie\/2010072_bb0215","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.2515\/therapie\/2010072_bb0220","first-page":"227","article-title":"R\u00f4le des infections virales dans le d\u00e9veloppement des toxidermies : le syndrome d\u2019hypersensibilit\u00e9 m\u00e9dicamenteuse","volume":"46","author":"Descamps","year":"2006","journal-title":"Rev Fr Allerg Immun Clin"},{"key":"10.2515\/therapie\/2010072_bb0225","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejim.2003.09.004","article-title":"DRESS syndrome associated with HHV-6 reactivation","volume":"14","author":"Ichiche","year":"2003","journal-title":"European Journal of Internal Medicine"},{"key":"10.2515\/therapie\/2010072_bb0230","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1528-1167.2008.01660.x","article-title":"Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests","volume":"49(9","author":"Aouam","year":"2008","journal-title":"Epilepsia"},{"key":"10.2515\/therapie\/2010072_bb0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2008.04.003","article-title":"Cross-reactivity pattern of rash from current aromatic antiepileptic drugs","volume":"80","author":"Alvestad","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.2515\/therapie\/2010072_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpes viruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allerg Inter"},{"key":"10.2515\/therapie\/2010072_bb0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2006.02.006","article-title":"Association of anticonvulsant hypersensitivity syndrome with herpesvirus 6, 7","volume":"70","author":"Oskay","year":"2006","journal-title":"Epilepsy Research"},{"key":"10.2515\/therapie\/2010072_bb0250","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.2515\/therapie\/2010072_bb0255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00002018-200932050-00003","article-title":"Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome","volume":"32","author":"Elzagallaai","year":"2009","journal-title":"Drug Safety"},{"key":"10.2515\/therapie\/2010072_bb0260","first-page":"14","article-title":"Valeurs diagnostique et pr\u00e9dictive des tests cutan\u00e9s aux m\u00e9dicaments et substances biologiques","volume":"46","author":"Ponvert","year":"2006","journal-title":"Rev Fr Allerg Immun Clin"},{"issue":"4","key":"10.2515\/therapie\/2010072_bb0265","first-page":"321","article-title":"Therapeutic alternatives in a patient with DRESS syndrome induced by allopurinol","volume":"19","author":"Calogiuri","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"10.2515\/therapie\/2010072_bb0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1440-0960.1998.tb01275.x","article-title":"Hypersensitivity syndrome reaction to oral terbinafine","volume":"39","author":"Gupta","year":"1998","journal-title":"Australas J Dermatol"},{"issue":"5","key":"10.2515\/therapie\/2010072_bb0275","first-page":"321","article-title":"Drug neosensitization during anticonvulsant hypersensitivity syndrome","volume":"16","author":"Gaig","year":"2006","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716307259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716307259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T06:23:56Z","timestamp":1712039036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716307259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0040595716307259"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2010072","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}